The Truth About Ozempic and Muscle Loss

Quick Summary:

It’s hard to go a day without hearing something new about the latest diabetes and obesity medications, semaglutide and tirzepatide.

A 2024 review of clinical trial data on semaglutide, for instance, found that the proportion of lean body mass lost while losing weight ranged from 0% to 40%.

For their part, experts like Weintraub and Klein do endorse further research looking more closely at muscle (and bone) loss while taking these drugs.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Ed Cara

Category: Technology

Markets: United StatesMali

Topics: Weight loss In science Peptide therapeutics Muscle atrophy Glp 1 Obesity In denmark Peptide hormones Michael weintraub Samuel klein Glp 1 receptor agonist Semaglutide Health medical pharma Anti obesity medication Glucagon like peptide 1 Diabetes

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-06-14 @ 15:05:00 (1 weeks ago)

News Timezone: GMT -5:00

News Source URL: gizmodo.com

Language: English

Article Length: 1354 words

Reading Time: 8 minutes read

Sentences: 45 lines

Sentence Length: 31 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Gizmodo

News ID: 21254840

View Article Analysis

About Gizmodo

Main Topics: Technology

Official Website: gizmodo.com

Update Frequency: 17 posts per day

Year Established: 2002

Headquarters: United States

News Last Updated: 16 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #30

Publisher Details

Frequently Asked Questions